BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35404897)

  • 1. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
    Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
    Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting.
    Chen W; Butler RK; Lustigova E; Chari ST; Wu BU
    Dig Dis Sci; 2021 Jan; 66(1):78-87. PubMed ID: 32112260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.
    Boursi B; Finkelman B; Giantonio BJ; Haynes K; Rustgi AK; Rhim AD; Mamtani R; Yang YX
    Gastroenterology; 2017 Mar; 152(4):840-850.e3. PubMed ID: 27923728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.
    Sharma A; Kandlakunta H; Nagpal SJS; Feng Z; Hoos W; Petersen GM; Chari ST
    Gastroenterology; 2018 Sep; 155(3):730-739.e3. PubMed ID: 29775599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is diabetes onset at advanced age a sign of pancreatic cancer?
    Ozsay O; Karabacak U; Cetin S; Majidova N
    Ann Ital Chir; 2022; 93():476-480. PubMed ID: 36156490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Models Screen New-Onset Diabetics at Low Risk of Early-Onset Pancreatic Cancer.
    Khan S; Al Heraki S; Kupec JT
    Pancreas; 2021 Oct; 50(9):1326-1330. PubMed ID: 34860819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database.
    White MJ; Sheka AC; LaRocca CJ; Irey RL; Ma S; Wirth KM; Benner A; Denbo JW; Jensen EH; Ankeny JS; Ikramuddin S; Tuttle TM; Hui JYC; Marmor S
    J Public Health (Oxf); 2023 Jun; 45(2):e266-e274. PubMed ID: 36321614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Pancreatic Cancer in the UK Biobank Cohort Using Polygenic Risk Scores and Diabetes Mellitus.
    Sharma S; Tapper WJ; Collins A; Hamady ZZR
    Gastroenterology; 2022 May; 162(6):1665-1674.e2. PubMed ID: 35065983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort study.
    Jensen MH; Cichosz SL; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
    Pancreatology; 2023 Sep; 23(6):642-649. PubMed ID: 37422338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.
    Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG
    Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes.
    Wang L; Scott FI; Boursi B; Reiss KA; Williams S; Glick H; Yang YX
    Clin Gastroenterol Hepatol; 2022 Sep; 20(9):1997-2004.e7. PubMed ID: 34737092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.
    Chari ST; Maitra A; Matrisian LM; Shrader EE; Wu BU; Kambadakone A; Zhao YQ; Kenner B; Rinaudo JAS; Srivastava S; Huang Y; Feng Z;
    Contemp Clin Trials; 2022 Feb; 113():106659. PubMed ID: 34954100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Cost-Effectiveness of Risk-Based Pancreatic Cancer Screening in Patients With New-Onset Diabetes.
    Schwartz NRM; Matrisian LM; Shrader EE; Feng Z; Chari S; Roth JA
    J Natl Compr Canc Netw; 2021 Jun; 20(5):451-459. PubMed ID: 34153945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of early pancreatic cancer in Japan.
    Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
    Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
    Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
    JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
    Maitra A; Sharma A; Brand RE; Van Den Eeden SK; Fisher WE; Hart PA; Hughes SJ; Mather KJ; Pandol SJ; Park WG; Feng Z; Serrano J; Rinaudo JAS; Srivastava S; Chari ST;
    Pancreas; 2018; 47(10):1244-1248. PubMed ID: 30325864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.
    Illés D; Ivány E; Holzinger G; Kosár K; Adam MG; Kamlage B; Zsóri G; Tajti M; Svébis MM; Horváth V; Oláh I; Márta K; Váncsa S; Zádori N; Szentesi A; Czakó B; Hegyi P; Czakó L
    BMJ Open; 2020 Nov; 10(11):e037267. PubMed ID: 33444177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.